Previous studies have reported numerous BET inhibitor-regulated genes in different cancers.81,85,86 BET inhibitors primarily function in hematologic malignancies by suppressing the transcriptional expression of BCL2 and c-MYC, two proto-oncogenes.4,80. The gene discussed is DNER; the disease is hematologic disorder.